Abstract Background Coronavirus disease-19 (COVID-19) infection is associated with an
uncontrolled systemic inflammatory response. Statins, given their anti-inflammatory …

The coronavirus disease-2019 (COVID-19) is caused by SARS-CoV-2, leading to acute
respiratory distress syndrome (ARDS), thrombotic complications, and myocardial injury …

Background and aims The idea of treating COVID-19 with statins is biologically plausible,
although it is still controversial. The systematic review and meta-analysis aimed to address …

Background: Recent epidemiological studies remain controversial regarding the association
between statin use and reducing the risk of mortality among individuals with COVID-19 …

Background There is an urgent need for novel therapeutic strategies for reversing COVID-19-
related lung inflammation. Recent evidence has demonstrated that the cholesterol-lowering …

Background: Statins have multiple protective effects on inflammation, immunity and
coagulation, and may help alleviate pneumonia. However, there was no report focusing on …

Purpose COVID-19 is characterized by dysfunctional immune responses and metabolic
derangements, which in some, lead to multi-organ failure and death. Statins are …

The worsening progress of coronavirus disease 2019 (COVID-19) is attributed to the
proinflammatory state, leading to increased mortality. Statin works with its anti-inflammatory …

Objective: Although statins are widely prescribed lipid-lowering drugs, there are concerns
about the safety of their use in the context of coronavirus disease 2019 (COVID-19), since …

Abstract The coronavirus disease 2019 (COVID-19) can result in a hyperinflammatory state,
leading to acute respiratory distress syndrome (ARDS), myocardial injury, and thrombotic …